Antibiotic prescribing for acute, non-complicated infections in primary care in Germany: baseline assessment in the cluster randomized trial ARena.
Acute upper respiratory tract infections
Antibiotic prescribing
Antimicrobial resistance
Mixed logistic regression model
Primary care
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
26 Aug 2021
26 Aug 2021
Historique:
received:
01
02
2021
accepted:
12
08
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
25
9
2021
Statut:
epublish
Résumé
Antimicrobial resistance is fueled by inappropriate use of antibiotics. Global and national strategies support rational use of antibiotics to retain treatment options and reduce resistance. In Germany, the ARena project (Sustainable reduction of antibiotic-induced antimicrobial resistance) intended to promote rational use of antibiotics for acute non-complicated infections by addressing network-affiliated physicians, primary care teams and patients through multiple interacting interventions. The present study documented patterns of antibiotic prescribing for patients with acute non-complicated infections who consulted a physician in these networks at the start of the ARena project. It explored variation across subgroups of patients and draws comparisons to prescribing patterns of non-targeted physicians. This retrospective cross-sectional analysis used mixed logistic regression models to explore factors associated with the primary outcome, which was the percentage of patient cases with acute non-complicated respiratory tract infections consulting primary care practices who were treated with antibiotics. Secondary outcomes concerned the prescribing of different types of antibiotics. Descriptive methods were used to summarize the data referring to targeted physicians in primary care networks, non-targeted physicians (reference group), and patient subgroups. Overall, antibiotic prescribing rates were 32.0% in primary care networks and 31.7% in the reference group. General practitioners prescribed antibiotics more frequently than other medical specialist groups (otolaryngologists vs. General practitioners OR = 0.465 CI = [0.302; 0.719], p < 0.001, pediatricians vs. General practitioners: OR = 0.369 CI = [0.135; 1.011], p = 0.053). Quinolone prescribing rates were 9.9% in primary care networks and 8.1% in reference group. Patients with comorbidities had a higher likelihood of receiving an antibiotic and quinolone prescription and were less likely to receive a guideline-recommended substance. Younger patients were less likely to receive antibiotics (OR = 0.771 CI = [0.636; 0.933], p = 0.008). Female gender was more likely to receive an antibiotic prescription (OR = 1.293 CI = [1.201, 1.392], p < 0.001). This study provided an overview of observed antibiotic prescribing for acute non-complicated respiratory tract infections in German primary care at the start of the ARena project. Findings indicate potential for improvement and will serve as comparator for the post-interventional outcome evaluation to facilitate describing of potential changes.
Sections du résumé
BACKGROUND
BACKGROUND
Antimicrobial resistance is fueled by inappropriate use of antibiotics. Global and national strategies support rational use of antibiotics to retain treatment options and reduce resistance. In Germany, the ARena project (Sustainable reduction of antibiotic-induced antimicrobial resistance) intended to promote rational use of antibiotics for acute non-complicated infections by addressing network-affiliated physicians, primary care teams and patients through multiple interacting interventions. The present study documented patterns of antibiotic prescribing for patients with acute non-complicated infections who consulted a physician in these networks at the start of the ARena project. It explored variation across subgroups of patients and draws comparisons to prescribing patterns of non-targeted physicians.
METHODS
METHODS
This retrospective cross-sectional analysis used mixed logistic regression models to explore factors associated with the primary outcome, which was the percentage of patient cases with acute non-complicated respiratory tract infections consulting primary care practices who were treated with antibiotics. Secondary outcomes concerned the prescribing of different types of antibiotics. Descriptive methods were used to summarize the data referring to targeted physicians in primary care networks, non-targeted physicians (reference group), and patient subgroups.
RESULTS
RESULTS
Overall, antibiotic prescribing rates were 32.0% in primary care networks and 31.7% in the reference group. General practitioners prescribed antibiotics more frequently than other medical specialist groups (otolaryngologists vs. General practitioners OR = 0.465 CI = [0.302; 0.719], p < 0.001, pediatricians vs. General practitioners: OR = 0.369 CI = [0.135; 1.011], p = 0.053). Quinolone prescribing rates were 9.9% in primary care networks and 8.1% in reference group. Patients with comorbidities had a higher likelihood of receiving an antibiotic and quinolone prescription and were less likely to receive a guideline-recommended substance. Younger patients were less likely to receive antibiotics (OR = 0.771 CI = [0.636; 0.933], p = 0.008). Female gender was more likely to receive an antibiotic prescription (OR = 1.293 CI = [1.201, 1.392], p < 0.001).
CONCLUSION
CONCLUSIONS
This study provided an overview of observed antibiotic prescribing for acute non-complicated respiratory tract infections in German primary care at the start of the ARena project. Findings indicate potential for improvement and will serve as comparator for the post-interventional outcome evaluation to facilitate describing of potential changes.
Identifiants
pubmed: 34445964
doi: 10.1186/s12879-021-06571-0
pii: 10.1186/s12879-021-06571-0
pmc: PMC8394572
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
877Subventions
Organisme : G-BA
ID : 01NVF16008
Investigateurs
Joachim Szecsenyi
(J)
Michel Wensing
(M)
Martina Kamradt
(M)
Regina Poß-Doering
(R)
Dorothea Kronsteiner
(D)
Petra Kaufmann-Kolle
(P)
Edith Andres
(E)
Veit Wambach
(V)
Joerg Lindenthal
(J)
Julian Bleek
(J)
Alexander Günter
(A)
Lutz Bader
(L)
Informations de copyright
© 2021. The Author(s).
Références
J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi3-12
pubmed: 22096064
BMJ. 2019 Dec 11;367:l6461
pubmed: 31826860
Antimicrob Resist Infect Control. 2020 Jan 6;9(1):6
pubmed: 31921412
J Antimicrob Chemother. 2010 Jul;65(7):1521-5
pubmed: 20494927
PLoS One. 2020 May 19;15(5):e0233345
pubmed: 32428012
BMC Fam Pract. 2019 Jul 2;20(1):91
pubmed: 31266449
Med Care. 2005 Nov;43(11):1130-9
pubmed: 16224307
GMS Hyg Infect Control. 2018 Mar 13;13:Doc04
pubmed: 29619292
Implement Sci. 2018 Mar 20;13(1):47
pubmed: 29554972
PLoS One. 2017 Mar 28;12(3):e0174584
pubmed: 28350820
Dtsch Arztebl Int. 2016 Jul 1;113(26):454-9
pubmed: 27412990
Antibiotics (Basel). 2020 Dec 08;9(12):
pubmed: 33302559
Ann Fam Med. 2019 Mar;17(2):125-132
pubmed: 30858255
Implement Sci. 2018 Feb 05;13(1):23
pubmed: 29402306
BMC Infect Dis. 2018 May 4;18(1):208
pubmed: 29728063
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
BMC Pediatr. 2014 Jul 05;14:174
pubmed: 24997585
J Antimicrob Chemother. 2019 Jul 1;74(7):2098-2105
pubmed: 31002333